S5 Ep37: Sekeres Previews Potential Combination Strategies in HR-MDS
S5 Ep36: FDA Approval Insights: Nivolumab Plus Chemo for Frontline Gastric Cancer
S5 Ep35: Krie and Yuan Talk Toxicity Management in Breast Cancer
S5 Ep34: DFCI Faculty Relay Insight Into Confirmed Rebounds of Cancer Screenings After COVID-19
S5 Ep33: Chachoua on Leveraging Screening Opportunities in Lung Cancer
S5 Ep32: Making the Most of Molecular Testing in Breast Cancer
S5 Ep31: FDA Approval Insights: Isatuximab Plus Carfilzomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
S5 Ep30: Research Reflections: Weber Relays Melanoma Updates From the 2021 ASCO Annual Meeting
S5 Ep29: Rariy Reviews In-Home Infusion Initiative in Oncology
S5 Ep28: Understanding Actionable Pathogenic Variants Among Caribbean Patients With Breast and Ovarian Cancers
S5 Ep27: Analyzing the Advancing Applications for Next-Generation Sequencing in Lung Cancer
S5 Ep26: FDA Approval Insights: Sacituzumab Govitecan in Urothelial Cancer
S5 Ep25: Jabbour on Tailoring Treatment With TKIs in CML and Ph+ ALL
S5 Ep24: Mayer on the Optimization of SERDs in ER+ Breast Cancer
S5 Ep23: Wainberg Weighs In on Advances in HER2+ GI Cancers
S5 Ep22: CTCA Leaders Provide Post-Pandemic Predictions in Oncology
S5 Ep21: Research Reflections: O'Malley Relays Key Updates in Ovarian and Endometrial Cancers
S5 Ep20: Sherman Spotlights Advances With RET Inhibitors in Medullary Thyroid Cancer
S5 Ep19: Lee-Kim on Fostering a Fulfilling Fellowship in Oncology
S5 Ep18: Halmos Highlights Effort Exploring COVID-19 Vaccines in Patients With Cancer
S5 Ep17: Matsen Reflects on Changes to Breast Cancer Surgery During COVID-19
S5 Ep16: George Gives Take on Optimal Sequencing, Strategies in Pancreatic Cancer Pipeline
S5 Ep15: Pant Projects an Expanding Role for Targeted Therapy in Pancreatic Cancer
S5 Ep14: Patel Previews Collaborative Research Program With SD-101 in Uveal Melanoma
S5 Ep13: FDA Approval Insights: Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma
S1 Ep1: FDA Approval Insights: Tivozanib in Relapsed/Refractory Advanced RCC
S5 Ep12: Landgren Breaks Down the Benefit of Novel Quadruplet in Newly Diagnosed Myeloma
S5 Ep11: Baumann Characterizes the Current Treatment Landscape of Merkel Cell Carcinoma
S5 Ep10: Kaklamani Speaks to a Shifting HER2+ Breast Cancer Paradigm
S5 Ep9: UCSD Faculty Contextualize Cases of Cutaneous Squamous Cell Carcinoma
S5 Ep8: Grivas and Wright Weigh In on the Benefits of Multidisciplinary Care in Bladder Cancer
S5 Ep7: O'Dea Offers Insight Into the Integration of Trastuzumab Deruxtecan in HER2+ Breast Cancer
S5 Ep6: Federico Outlines Needs, Nuances, and Necessities in Neuroblastoma Treatment
S5 Ep5: FDA Approval Insights: Cemiplimab in Advanced PD-L1–High NSCLC and Advanced Basal Cell Carcinoma
S5 Ep4: FDA Approval Insights: Liso-Cel in Refractory Large B-Cell Lymphoma
S5 Ep3: Riedel and Van Tine Spotlight Sarcoma Advances and Preview Ongoing Studies
S5 Ep2: FDA Approval Insights: TheraSphere Y-90 Glass Microspheres in HCC
S5 Ep1: Pagel Unpacks the Utility of PI3K Inhibitors in Lymphoid Malignancies
S4 Ep50: Saba Spotlights the Nuances of Treating Nasopharygeal Cancer
S4 Ep49: Research Reflections: Sonpavde on Urothelial Cancer Updates From the 2021 GU Cancers Symposium
S4 Ep48: FDA Approval Insights: Umbralisib in Marginal Zone Lymphoma and Follicular Lymphoma
S4 Ep47: FDA Approval Insights: Trilaciclib in Extensive-Stage Small Cell Lung Cancer
S4 Ep46: Choueiri and Motzer Chat on CheckMate-9ER and Other RCC Research
S4 Ep45: The Marshalls Open a Candid Conversation About Cancer
S4 Ep44: Hu Highlights Recent Advances and Approvals in RET-Altered Thyroid Cancer
S4 Ep43: Coleman and Brown Review Advancing Applications for PARP Inhibition in Ovarian Cancer
S4 Ep42: Borgen Breaks Down the Domino Effect of Expanded Education and Banished Stigmas in Male Breast Cancer
S4 Ep41: Monk and Herzog Hammer Out PARP Nuances in Ovarian Cancer
S4 Ep40: Spira Spotlights Sotorasib and Targeting KRAS Mutations in NSCLC
S4 Ep39: Levy Lauds Biomarker-Driven Data in Lung Cancer
next page